End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.08 PLN | -11.11% | -.--% | -.--% |
2023 | Remedis SA Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
2023 | Remedis SA Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022 | CI |
Sales 2021 | -298K -74.27K -102K | Sales 2022 | -711K -177K -243K | Capitalization | 3.77M 938K 1.29M |
---|---|---|---|---|---|
Net income 2021 | - 0 0 | Net income 2022 | -2M -498K -683K | EV / Sales 2021 | -44.8 x |
Net Debt 2021 | 5.77M 1.44M 1.97M | Net Debt 2022 | 6.72M 1.67M 2.29M | EV / Sales 2022 | -14.8 x |
P/E ratio 2021 |
-10.2
x | P/E ratio 2022 |
-1.41
x | Employees | 3 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 10.17% |
1 day | -11.11% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 59 | 19-06-24 | |
Director/Board Member | 33 | 14-06-23 | |
Kamil Krajewski
BRD | Director/Board Member | - | 21-01-13 |
1st Jan change | Capi. | |
---|---|---|
-.--% | 1.26M | |
+25.58% | 19.01B | |
+35.11% | 17.61B | |
+8.58% | 9.64B | |
-10.88% | 8.6B | |
+5.52% | 6.47B | |
+74.76% | 5.79B | |
+1.64% | 5.01B | |
+62.35% | 4.45B | |
-3.57% | 4.23B |
- Stock Market
- Equities
- REM Stock